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Available online 15 August 2016Kinetic oscillatory stimulation (KOS) in the nasal cavity is a non-invasive cranial nerve stimulation method with
promising efﬁcacy for acutemigraine and other inﬂammatory disorders. For a better understanding of the under-
lying neurophysiological mechanisms of KOS treatment, we conducted a resting-state functional magnetic reso-
nance imaging (fMRI) study of 10 acute migraine patients and 10 normal control subjects during KOS treatment
in a 3 T clinical MRI scanner. The fMRI data were ﬁrst processed using a group independent component analysis
(ICA) method and then further analyzed with a voxel-wise 3-way ANOVAmodeling and region of interest (ROI)
of functional connectivity metrics.
All migraine participants were relieved from their acutemigraine symptoms after 10–20min KOS treatment and
remained migraine free for 3–6 months. The resting-state fMRI result indicates that migraine patients have al-
tered intrinsic functional activity in the anterior cingulate, inferior frontal gyrus and middle/superior temporal
gyrus. KOS treatment gave rise to up-regulated intrinsic functional activity for migraine patients in a number
of brain regions involving the limbic and primary sensory systems, while down regulating temporally the activity
for normal controls in a few brain areas, such as the right dorsal posterior insula and inferior frontal gyrus.
The result of this study conﬁrms the efﬁcacy of KOS treatment for relieving acutemigraine symptoms and reduc-
ing attack frequency. Resting-state fMRI measurements demonstrate that migraine is associated with aberrant
intrinsic functional activity in the limbic and primary sensory systems. KOS in the nasal cavity gives rise to the
adjustment of the intrinsic functional activity in the limbic and primary sensory networks and restores the phys-
iological homeostasis in the autonomic nervous system.
© 2016 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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3-Way ANOVA1. Introduction
Migraine is a common, neurological disorder characterized by severe
headache and affecting approximately 18% of women and 6% of men
(Friedman and De ver Dye, 2009; Scher et al., 2005; Schwedt et al.,
2015). Triptans such as sumatriptan are widely used for acute symptom
relief ofmigraine headaches. About 2% of the population suffers from re-
fractory chronic migraine and the trigeminal autonomic cephalalgias
(TACs), which is often associated with drug-resistance, disability and
low quality of life.
There exist a number of theories trying to account for the ethnology
of migraine. For example, inadequate regulation of the autonomic ner-
vous system (ANS) (Ebinger et al., 2006; Geraud and Donnet, 2013;
Melek et al., 2007), derangement of serotonin metabolism (Dussor,
2014; Hoffmann and Goadsby, 2014; Vollbracht and Rapoport, 2014),Physics, Karolinska University
en access article under the CC BY-NCinsensitive reaction to reduced oxygen in the vasculature and tissue
(Friberg et al., 1994; Lacombe et al., 1992; Raddant and Russo, 2014),
disruption of the normal pain pathways (Kroger and May, 2015), pecu-
liar platelet metabolism (Danese et al., 2014; Gawel and Rose, 1982;
Hanington, 1989), neurogenic inﬂammation (Tajti et al., 2015) and
etc. (Alstadhaug, 2014). Researchers have yet to disseminate a uniﬁed
theory to account for the different aspects of the complex pathophysiol-
ogy of migraine. Despite extensive neuroimaging studies of headache
disorders in the last decade (Arkink et al., 2012; Charles, 2013; Kroger
and May, 2014; Lipton et al., 2014; Maniyar et al., 2014; Maniyar et al.,
2015; May, 2013; Montagna et al., 2010; Morelli et al., 2013; Moulton
et al., 2014; Robert et al., 2013; Sahler, 2013; Schwedt et al., 2015;
Seifert et al., 2012; Zielman et al., 2014), functional imaging acquired
during transient attack of migraine has been quite rare. Such studies
can provide important insight into the pathogenesis of migraine head-
aches. Earlier PET studies have shown persisting activation in the
brain stem and hypothalamus during migraine attacks (Bahra et al.,
2001; Geraud et al., 2005). MRI studies based on arterial spin labeling
(ASL) have also reported hemodynamic abnormality in the-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Summary of the clinical information for the 10 migraine patients.
Patient Sex Age Pain Pain free period KOS repetition
1 f 40 7 6 months 2
2 m 37 6 3 months 1
3 m 43 7 3 months 1
4 f 35 8 6 months 4
5 f 41 5 5 months 1
6 f 53 6 6 months 2
7 m 61 8 5 months 3
8 m 61 4 3 months 2
9 m 42 5 3 months 2
10 f 31 4 3 months 2
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2012; Kato et al., 2010; Pollock et al., 2008). These ﬁndings have led to
the hypothesis that hypothalamic pathway might play a critical role in
the pathogenesis of migraine attacks (Moulton et al., 2014; Robert et
al., 2013; Schwedt et al., 2015). Results from neuroimaging and spec-
troscopy studies of TACs provided further evidence for this view
(Iacovelli et al., 2012; Lodi et al., 2006; Wang et al., 2006). For TACs
and refractory migraine, hypothalamic deep brain stimulation has
been tested as an alternative treatment and symptom reduction has
been observed in some patients (Altinay et al., 2015; Palmisani et al.,
2013).
Taking advantages of the rich innervations and inter-nerve connec-
tions in the nasal mucous membrane, we have recently developed a
non-invasive approach based on kinetic oscillatory stimulation (KOS)
in the nasal cavity for the treatment of migraine (Juto and Hallin,
2015) and other chronic inﬂammatory disorders (Juto and Axelsson,
2014). We have completed a randomized control trial (RCT) study
(ClinicalTrials.gov Identiﬁer: NCT01488110) based on 36 migraine pa-
tients and showed that KOS in the nasal cavity is an effective and safe
method to relieve both acute pain and reduce the attack frequency in
patients with migraine (Juto and Hallin, 2015). Multi-site clinical RCT
studies for further testing its efﬁcacy on acute migraine (ClinicalTrials.
gov Identiﬁer: NCT02185703) and prophylactic effects (ClinicalTrials.
gov Identiﬁer: NCT02243865) are currently under way.
The purpose of this study is to improve our understanding of the
neurological underpinnings for KOS treatment of acute migraine. Such
understanding may provide guidance for further optimization of the
procedure and extension of KOS method for other clinical applications
in addition to the treatment of migraine. We used blood oxygen-level
dependent (BOLD) functionalmagnetic resonance imaging (fMRI) tech-
nique to study the alterations in the functional connectivity in the brain
in response to the KOS treatment. We compare the resting-state func-
tional connectivity differences between patients with acute migraine
and normal volunteers before, during and after KOS treatment. We
demonstrate that migraine headache is associated with abnormal in-
trinsic functional connectivity in the limbic system, which is the central
brain network for ANS control and KOS treatment can regulate the func-
tional connectivity of the limbic system back to normal status.2. Materials and methods
2.1. Recruitment and clinical evaluation of the migraine patients
We recruited 10 adult patients (male/female= 5/5, age= 44± 10)
and 10 normal controls (male/female = 5/5, age = 43 ± 11) into the
study. The patients were previously diagnosed withmigraine according
to the ICHD-2 classiﬁcation and experienced at least onemigraine attack
per month before participating in the study. The migraine patients had
no other signiﬁcant disease. The patients contacted the investigators
by phone at typical signs of an attack development. Their headache
had to fulﬁll the ICHD-2 criteria and reach at least 4.0 on the pain visual
analog scale (VAS) 0–10. VAS = 0 presents no pain and VAS = 10 the
highest level of unbearable pain.We administered the actual KOS treat-
ment inside a clinical MRI scanner within 30 min of arrival on site. Pa-
tients were asked not to take any medication before the KOS
treatment (see Table 1) (Li et al., 2014, 2015b).
The VAS assessment of pain was conducted immediately before the
KOS treatment, every 10 min during treatment, at the end of the treat-
ment and 15 min after treatment. All patients were also asked to assess
their general well-being immediately before and following the treat-
ment. The pain level was also assessed 24 h after by telephone inter-
view. After the KOS treatment the patients were requested to continue
with their VAS assessment of pain and report to the investigators. In
case ofmigraine reoccurrence, we provided the patientswith the option
of repeated KOS treatments.2.2. KOS treatment
KOS in the nasal cavity was administered using the similar equip-
ment described in our previous studies (Juto and Axelsson, 2014; Juto
and Hallin, 2015; Li et al., 2014, 2015b). It consists of a controller unit
connected to a single-use catheter through a 7 m long plastic tube,
which can deliver oscillatory stimulations to the nasal mucosa, while
the patients were positioned inside the MRI scanner for fMRI measure-
ments. The catheter coatedwith lubricating liquid (medical grade paraf-
ﬁn or water) was inserted into the nasal cavity on the side with the
predominant pain. We chose to treat the right side ﬁrst, if the patients
had no lateralization with their symptoms. For active treatment of mi-
graine, the tip was inﬂated and oscillated for 10 min at the pressure of
95 mbar and frequency of 68 Hz. After 10min the oscillations were ter-
minated and the patients were asked to assess their pain level. In case of
some remaining pains, the catheter was deﬂated and moved to the
other side, re-inﬂated and the treatment continued for another 10 min.
It should be noted that the device can deliver KOS inside the entire
nasal cavity, extending deep in the proximity of the pterygopalatina
ganglion (PPG). The settings (pressure and frequency) and treatment
duration are based on previous clinical experience (Juto and Axelsson,
2014; Juto and Hallin, 2015) and are usually optimized for each speciﬁc
disorder and patient sub-groups. For example, the optimal settings for
the treatment of non-allergic rhinitis were 50 mbar and 50 Hz (Juto
and Axelsson, 2014), whereas 95 mbar and 68 Hz are more effective
for acute migraine (Juto and Hallin, 2015; Li et al., 2014, 2015b).2.3. fMRI data acquisition
The fMRI measurements were conducted using a 3 T whole-body
clinical MRI scanner (TIM Trio, Siemens Healthcare, Erlangen, Germa-
ny). A single-shot 2D gradient-recalled echo echo-planar imaging
pulse sequence was used for the data acquisition with the following
main acquisition parameters: 32 transverse slices, slice thickness =
3.6 mm, TR/TE = 2000/35 ms, FOV = 220 mm, matrix size = 64 × 64,
ﬂip angle = 90°, 300 dynamic timeframes, and IPAT = 2. A 32-channel
phased-array head coil was used for the signal reception. Foam padding
was used to for each subject to reduce involuntary head motions.
For each migraine subject we conducted 4–5 sessions of BOLD fMRI
scans lasting 10min per session. Themigraine headachewas on going at
the time of arrival for fMRI. Prior to the active KOS treatment, we per-
formed two control resting-state fMRI scans for each patient. A baseline
measurement session without inserted probe (denoted as Base1) and
another sessionwith inserted catheter but no active oscillatory stimula-
tions (denoted as Probe). Depending on the symptom assessment if the
migraine pain diminished completely after one session,we administrat-
ed one or two sessions of active KOS treatment for each patient inside
theMRI scannerwhile continuous BOLD fMRI recordingwas also carried
out (denoted as KOS). However, to facilitate comparison only the data
acquired during KOS treatment of the right nasal cavity entered into
the analysis. At the end, we performed also a post-treatment control
453T.-Q. Li et al. / NeuroImage: Clinical 12 (2016) 451–459session of resting-state fMRI scan (Base2) after removing the KOS
catheter.
Since KOS in nasal cavity is a non-invasive treatment, for comparison
we applied the same treatment procedure and fMRI protocol described
above to the normal controls. The active KOS treatment was adminis-
trated on both sides with the order of right to left.2.4. fMRI data pre-processing
The resting-state fMRI datasets underwent a pipeline of preprocess-
ing procedure, which were performed with AFNI (http://afni.nimh.nih.
gov/afni) and FSL (http://www.fmrib.ox.ac.uk/fsl) programs with a
bash wrapper shell(Wang and Li, 2013, 2015). The ﬁrst 10 timeframes
in each data set were removed to ensure signal steady state. After tem-
poral de-spiking, six-parameter rigid body image registration was per-
formed for motion correction. The average volume for each motion-
corrected time series was used to generate a brain mask to minimize
the inclusion of the extra-cerebral tissues. Spatial normalization to the
standard MNI template was performed using a 12-parameter afﬁne
transformation andmutual-information cost function. During the afﬁne
transformation the imaging data were also re-sampled to isotropic res-
olution using a Gaussian kernel with 4 mm full width at half maximum
(FWHM). Nuisance signal removal was achieved by voxel-wise regres-
sion using 16 regressors based on themotion correction parameters, av-
erage signal of the ventricles, average signal of the core white matter
and their 1st order derivatives. After baseline trend removal up to the
third order polynomial, effective band-pass ﬁltering was performed
using low-pass ﬁltering at 0.08 Hz. At last local Gaussian smoothing
up to FWHM = 6 mm was performed using an eroded gray matter
mask.2.5. Group ICA and statistical assessment
To create group level functional connectivity network parcellation
we performed ICA on the pre-processed resting-state fMRI data using
the GIFT toolbox (mialab.mrn.org/software) implemented in MATLAB
(MathWorks, Massachusetts, USA). It included a series of analytical
steps similar to the standard group ICA procedure (Wang and Li, 2013,
2015). Individual datasets were ﬁrst concatenated and then followed
by computation of the individual ICA components and corresponding
time courses. Data reduction based on principle component analysis
was performed at the subject and group levels prior to ICA. The Infomax
algorithm was then applied to estimate the aggregate independent
components (ICs). Lastly, subject speciﬁc spatial maps and time courses
were estimated using the direct group ICA back-reconstruction ap-
proach. Toprepare the subject speciﬁc ICA results for higher-level statis-
tical assessment, the subject speciﬁc ICA results were rescaled with z-
transformation.
To investigate how the speciﬁed number of independent compo-
nents (NIC) inﬂuences ICA results, we performed group ICA of the
pooled resting-state fMRI data with NIC systematically incremented
from 2 to 19. We manually inspected the spatial distributions of the
one-sampled t-test results of all ICs and the corresponding time courses
to exclude possible artifacts. All non-artifacts ICs are considered as po-
tential resting-state functional networks (RFNs). Mask was created for
each potential RFN by imposing a voxel-wise t-score threshold of
t ≥ 4.0 (p ≥ 0.0008, uncorrected) and a minimum cluster size S ≥ 20.
This guarantees a family-wise error rate (FWER) p ≤ 0.01, as estimated
by using the AFNI program, AlphaSim+ with following inputs: voxel-
wise p b 0.0008, FWHM = 6.2 mm, and 106 iterations. FWHM =
6.2 mm was the estimated average by applying the AFNI program,
3dFWHMx, to the ﬁnal smoothed fMRI data, which was quite close
to FWHM = 6 mm used in the ﬁnal smoothing procedure described
above.2.6. Statistics
We performed voxel-wise 3-way analysis of variance (ANOVA) of
the ICA results to assess the functional connectivity differences between
migraine patients and normal controls measured before, during and
after the KOS treatment. We used the AFNI program, 3dANOVA3 with
the model option of type = 5. In the model there are two ﬁxed factors.
One is the group difference betweenmigraine patients and normal con-
trols (degree of freedom, DF=1) and the other is the KOS treatment ef-
fect occurred in the four scanning sessions: Base1, Probe, KOS, and
Base2 (DF = 3). The participants in each group were modeled as a ran-
dom factor (DF=9).With the 3-way ANOVA, we can also assess the in-
teraction between the two ﬁxed factors and interrogate how the KOS
treatment affected differently the intrinsic functional activity in mi-
graine patients and healthy volunteers. We performed voxel-wise 3-
way ANOVA for each RFN and only voxels within the RFN mask are
considered.
The statistical signiﬁcance of the 3-way ANOVA result for a given
RFN was assessed ﬁrst by setting an uncorrected voxel-wise threshold
at p ≤ 0.01 and then by imposing a minimum voxel cluster size of at
least 20 contiguous voxels. The probability of random ﬁeld of noise pro-
ducing a cluster of size ≥ 20was estimated at p ≤ 0.05. This was conclud-
ed from the Monte-Carlo simulation result obtained by using the AFNI
program, AlphaSim+. For the simulations we used following input pa-
rameters: voxel-wise threshold value p ≤ 0.01, 106 iterations, the brain
mask and FWHM= 6.2 mm. The ﬁnal result for a given NIC is summa-
rized as the non-zero mean of the ANOVA results for all potential RFNs.
2.7. ROI analysis of the brain functional connectivity metrics
To investigate the effect of the actual KOS treatment versus probe in-
sertion we evaluated the brain functional connectivity for the ROIs
which exhibit signiﬁcant interaction between subject group and KOS
treatment. We used a quantitative data-driven (QDA) approach to de-
rive two metrics for quantifying the brain functional connectivity
changes. The QDA approach has been described by us in details else-
where (Nordin et al., 2016). In brief, the procedures used here are the
following: Firstly, we compute the voxel-wise cross-correlation coefﬁ-
cient (CC) matrix. That is for each voxel inside the brain, we compute
the Pearson's cross-correlation coefﬁcients of the r-fMRI time course
with that of every other voxel inside the brain. Secondly, we derive
two voxel-wise metrics from the CC matrix, which are the connection
strength index (CSI) deﬁned as the non-zero mean value of the
Pearson's cross-correlation coefﬁcients ≥ 0.3 for all voxel pairs involving
the current voxel in question and the connection counter index (CCI)
deﬁned as the number of voxel pairs involving the current voxel in
question with the Pearson's cross-correlation coefﬁcients ≥ 0.3. Lastly,
we calculate the CCI and CSI average values for the ROI masks derived
from the 3-way ANOVA.
3. Results
As summarized in Table 1, all migraine patients were fully relieved
from their acute headache symptoms after 10–20 min KOS treatment
inside the MRI scanner, which conﬁrms the result from previous RCT
study conducted outside the MRI scanner (Juto and Hallin, 2015). Fur-
thermore, the patients experienced a prolonged period up to 3–
6monthswithoutmigraine attacks, as assessed by telephone interviews
after the fMRI study.
Figs. 1–3 depict the one-sampled t-score maps of the group ICA re-
sults (FWER p ≤ 0.01) for NIC = 2–4, respectively. ICA parcellation
with low NIC produced over-determined and functionally less speciﬁc
networks. With increasing NIC, the detected RFNs become more func-
tional speciﬁc. E.g. at the minimum NIC = 2, we observed the primary
sensory network consisting of the somatosensory motor, auditory and
visual systems (Fig. 1a) and the extended default mode network (Fig.
Fig. 1. The cross-sectional displays of the one-sampled t-score maps (t ≥ 4.0 and minimum cluster size of 20) for group ICA result at NIC = 2. (a) The somatosensory motor network in
combination with the auditory and visual systems. (b) The extended default mode network. The color bar indicates the t-score level.
454 T.-Q. Li et al. / NeuroImage: Clinical 12 (2016) 451–4591b). With NIC = 3, we observed an additional network (Fig. 2c)
consisting of several left-right mirrored frontoparietal areas and
corresponding to the combination of the left and right control
networks(Schultz et al., 2014; Smith et al., 2009). Further increasing
NIC = 4, we observe that the primary visual network (Fig. 3d) is split
off from the primary sensory network (Fig. 1a or Fig. 2a).
The 3-way ANOVA modeling of the ICA results at low NIC
produced very little statistical contrast. When NIC ≥ 7, the ICA
parcellation becomes sufﬁciently speciﬁc and renders signiﬁcantFig. 2. The cross-sectional displays of the one-sampled t-score maps (t ≥ 4.0 and minimum c
consisting of the somatosensory motor, auditory, and visual systems (a) and the extended de
control RFN (c) is also seen. The color bar indicates the t-score level.statistical contrast in the 3-way ANOVA of the ICA results. Figs. 4–6
depict the 3-way ANOVA results of the ICA results at NIC = 10. As
shown in Fig. 4 and Table 2, the brain regions with signiﬁcant
group effect in intrinsic functional activity include mainly anterior
cingulate, left inferior frontal gyrus and middle/superior temporal
gyri. The boxplots of the average z-score values for the ROIs with sig-
niﬁcant group effect (see Fig. 4) indicate that migraines patients
have reduced intrinsic activity in involved functional networks
(Fig. 7a and b).luster size of 20) for group ICA result at NIC = 3. Besides the primary sensory network
fault mode network (b) observed at NIC = 2, the symmetrically mirrored left- and right-
Fig. 3. The cross-sectional displays of the one-sampled t-score maps (t ≥ 4.0 and minimum cluster size of 20) for group ICA result at NIC = 4. Compared with the over determined ICs
observed at NIC = 3, the primary sensory network is split into two separate ICs. (a) The default mode network. (b) The somatosensory motor network. (c) The visual system. (d) The
symmetrically mirrored left- and right-control RFN. The color bar indicates the t-score level.
Fig. 4.Brain regionswith signiﬁcant subject group effect (migraine patients versus healthy
controls) in intrinsic functional activity at NIC = 10. The statistical signiﬁcance was
assessed with the 3-way ANOVA (model type = 5) at voxel-wise F-score threshold
F ≥ 7.385 (numerator DF = 1, denominator DF = 36, uncorrected p ≤ 0.01) and a
minimum cluster size of 20 contiguous voxels. The color bar indicates the F-score level.
Fig. 5. Brain regions with signiﬁcant KOS treatment effect on the instinct functional
activity at NIC = 10. The statistical signiﬁcance was assessed with the 3-way ANOVA
(model type = 5) at voxel-wise F-score threshold F ≥ 4.373 (numerator DF = 3,
denominator DF = 36, uncorrected p ≤ 0.01) and a minimum cluster size of 20
contiguous voxels. The color bar indicates the F-score level.
455T.-Q. Li et al. / NeuroImage: Clinical 12 (2016) 451–459
Fig. 6. Brain regions with signiﬁcant interaction effect between the twomainﬁxed factors.
That is, the brain regions where the KOS treatment resulted in signiﬁcantly difference in
the intrinsic functional activity (at NIC = 10) between migraine patients and normal
controls. The statistical signiﬁcance was assessed with the 3-way ANOVA (model
type = 5) at voxel-wise F-score threshold F ≥ 4.373 (numerator DF = 3, denominator
DF = 36, p ≤ 0.01 uncorrected) and a minimum cluster size of 20 contiguous voxels. The
color bar indicates the F-score level.
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mary sensory systems depicted statistically signiﬁcant KOS treatment
effect on the intrinsic functional activity. The involved brain regions in
the limbic system included anterior cingulate, anterior insula cortex, in-
ferior frontal gyrus, thalamus and hypothalamus. These brain areas are
important components of the cerebral central control network for the
autonomic nervous system. Boxplots of the average z-scores for the in-
volved ROIs are shown in Fig. 7c and d. It is clear that KOS treatment re-
sulted in up-regulated intrinsic functional activity during the treatment
in a large number of brain regions of the limbic and primary sensory sys-
tems. This trend of change with the KOS procedure is quite similar for
both migraine and control participants. However, there are a few
more speciﬁc regions (see Figs. 6, 7e and f) exhibited opposite trends
between the migraine and control groups. The involved brain regions
included dorsal posterior insula, lingual gyrus, precuneus and inferior
frontal gyrus.Table 2
List of brain regionswith signiﬁcant statistical contrast (FWERp ≤ 0.05) as identiﬁed by voxel-w
locations of ROIs in the standard MNI coordinates. The referred voxel size is 4 mm isotropic.
Statistical contrast ROI Volume (voxel) X (mm)
Group 1 110 0.0
2 49 +16.0
3 31 −49.0
Treatment 4 508 +52.0
5 411 −60.0
6 126 0.0
7 93 +37.0
8 81 −38.0
9 68 −52.0
10 48 −33.0
11 31 −31.0
12 48 +32.0
13 20 +41.0
14 32 0.0
15 23 0.0
16 34 −19.0
17 51 32.0
18 22 −38.0
Interaction 19 55 −15.0
20 24 −11.0
21 21 −40.0
22 20 −44.0The boxplots in Fig. 7 are the average ROI results of all CA coefﬁcients
in 10 networks. To study the speciﬁc change in the dorsal posterior
insula and inferior frontal gyrus we used also more direct ROI analysis
of the CCI and CSI metrics. As shown in Fig. 8, at baseline 1, the CCI
values for these brain regions were about the same for both migraine
patients and controls, but the CSI values for the migraine patients
were about ~7% lower. The probe insertion and the actual KOS treat-
ment reduced CCI by half and CSI by 10%in the normal controls. These
changes in CCI and CSI were almost fully recovered for the normal con-
trols after the treatment in baseline 2. However, tor the migraine pa-
tients the KOS treatment induced increases in both CCI and CSI. The
CCI restored back to the baseline level but the enhanced CSI remained
after the treatment. Therefore, the net result of KOS treatment was the
up-regulation of CSI in the migraine patients to the level closer to that
for the normal controls.
NIC affects the ICA outputs and, therefore, the ANOVA results de-
rived from it, as illustrated by the supplementary materials for NIC =
11 (see Figs. S1–S4). The outcomes from 3-way ANOVA modeling of
the ICA results for NIC = 2–19 demonstrate that some of the involved
brain regions displayed relatively stable ANOVA statistical contrast irre-
spective of the input NIC parameter, once NIC ≥ 7. Further details on this
can be found in the supplementary materials below.
4. Discussion
4.1. Important ﬁndings of the study
Major novel ﬁndings of the study are the following: 1) ICA result is
directly inﬂuenced by the input parameter NIC and NIC has to be sufﬁ-
ciently high to extract functionally speciﬁc connectivity networks for
further interrogation of clinically relevant questions; 2) migraine pa-
tients have altered intrinsic functional activity in anterior cingulate, in-
ferior frontal gyrus, insular cortex and middle/superior temporal gyri;
3) KOS treatment in the nasal cavity can effectively relieve acute mi-
graine symptoms and reduce attack frequency; 4) KOS treatment re-
sults in up-regulated intrinsic functional activity in a number of broad
brain regions of the limbic and somatosensory systems. However, for
migraine patients, the pain relief by the KOS treatment was accompa-
nied with up regulating of intrinsic functional activity in the inferior
frontal gyrus and dorsal posterior insula. A recent fMRI study based on
ASL technique has also shown that there is a signiﬁcant coupling be-
tween the regional cerebral blood ﬂow in the dorsal posterior insulaise 3-way ANOVAmodeling of the ICA results with NIC=10. X, Y, and Z represent the focal
Y (mm) Z (mm) LL/R Location label
−28.0 +34.0 B Anterior cingulate
−9.0 −17.0 L Inferior frontal gyrus
−1.0 −33.0 R Middle/superior temporal gyri
+12.0 +32.0 L Pre–postcentral gyrus
+14.0 +35.0 R Pre–postcentral gyrus
−13.0 +37.0 B Anterior cingulate
−12.0 +5.0 L Insula, inferior frontal gyrus
−14.0 +2.0 R Insula, inferior frontal gyrus
−8.0 −16.0 R Superior temporal gyrus
−48.0 +26.0 R Middle prefrontal gyrus
−22.0 +50.0 R Middle prefrontal gyrus
−45.0 +16.0 L Middle prefrontal gyrus
−28.0 +41.0 L Middle prefrontal gyrus
+5.0 +9.0 B Thalamus
−1.0 −14.0 B Hypothalamus
+96.0 +7.0 R Cuneus
+80.0 −11.0 L Lingual gyrus
+75.0 +43.0 R Superior parietal gyrus
+79.0 −4.0 R Lingual gyrus
+56.0 +31.0 R Dorsal posterior insula
−31.0 −9.0 R Precuneus
+28.0 +19.0 R Inferior frontal gyrus
Fig. 7. TheROI average of the IC coefﬁcients for brain regionswith signiﬁcant statistical contrasts (FWER, p ≤ 0.05) as detected by 3-way ANOVAmodeling of the group ICA results at NIC=
10. The group effect between normal controls (a) and migraine patients (b), KOS treatment effect (c and d), and interaction effect between the two main ﬁxed factors (e and f) are
displayed.
Fig. 8. The ROI average values of CCi are plotted against CSI for the dorsal posterior insula
and inferior frontal gyrus where exhibited signiﬁcant statistical (FWER, p ≤ 0.05)
interaction between the two main ﬁxed factors (subject group and KOS treatment) as
detected by the 3-way ANOVA modeling of the resting-state functional connectivity
data. The blue arrows indicate the start points of the experimental procedures and the 4
points in each curve represent the measurements conducted at baseline 1, probe
insertion, KOS treatment, and baseline 2, respectively. The lines between the data points
are connected to guide the eyes.
457T.-Q. Li et al. / NeuroImage: Clinical 12 (2016) 451–459and the intensity of experienced tonic pain and it has been proposed
that dorsal posterior insula is a speciﬁc brain region associated with
painful experience and a potential therapeutic target (Segerdahl et al.,
2015).
KOS of the nasal mucosa with low frequency mechanical vibrations
was initially developed to provide an alternative therapy for non-aller-
gic rhinitis (Juto and Axelsson, 2014). Completed single- and multi-site
RCT studies (ClinicalTrials.gov Identiﬁer: NCT01844336) have demon-
strated that a single KOS treatment has signiﬁcant impact on reducing
the nasal symptoms of persistent rhinitis (Juto and Axelsson, 2014).
The effect was most pronounced in the days immediately following
treatment butwas still present twoweeks post-treatment.More recent-
ly, an exploratory trials study to test the efﬁcacy of KOS treatment on
acute migraine patients demonstrated that this treatment has a surpris-
ingly fast-acting remedy for acutemigraine pain (Juto andHallin, 2015).
Results from the present study conﬁrm that KOS is indeed an effective
and safe treatment for acute migraine (Juto and Hallin, 2015; Li et al.,
2014, 2015b). Comparing with existing treatments for migraine, KOS
therapy has the following beneﬁts: 1) easy to administer; 2) well toler-
ated by the patients; 3) no involvement of pharmaceuticals; 4) very few
and mild side effects. KOS in the nasal cavity has the potential to offer a
viable alternative both for acute symptom relief and long-term
prevention.
4.2. Underlying neurophysiological mechanisms for KOS treatment of
migraine
The mechanisms of KOS treatment have not been fully understood.
Besides the altered intrinsic functional activities observed in the present
study, themeasurements of heart rate variability (HRV) during the KOS
treatments of migraine patients (not shown) indicate also active re-
sponses in the ANS, particularly in the parasympathetic tone. It appears
that the intervention has a positive impact on the functioning of ANS
458 T.-Q. Li et al. / NeuroImage: Clinical 12 (2016) 451–459possibly by restoring homeostasis in the basal parts of the brain and the
hypothalamic area, which are responsible for short-term ANS control.
The observed changes in intrinsic functional activity in the limbic sys-
tem in association with the pain relief by KOS treatment reﬂect more
likely the intermediate and longer-term adjustment of ANS by the cen-
tral nervous control network.
It has been previously demonstrated that electrical stimulation of
the PPG can mitigate severe symptoms in primary headaches (Altinay
et al., 2015; Palmisani et al., 2013), implying that the stimulation of
PPG by the KOS treatment in the nasal cavity is at least partly responsi-
ble for themigraine pain relief through the trigeminal parasympathetic
reﬂex. Recent studies provided new anatomic insight into the PPG in-
nervation of the posterolateral nasal mucosa (Bleier and Schlosser,
2011; Li et al., 2015a; Li et al., 2010). Neurons project from the PPG via
multiple individual postganglionic rami to supply the nasal mucosa
(Bleier and Schlosser, 2011) and PPG is directly connected to hypothal-
amus through the parasympathetic ﬁbers from the superior salivatory
nucleus (Li et al., 2015a; Li et al., 2010). Growing evidence from func-
tional imaging studies indicates that hypothalamus plays a very impor-
tant role in the pathogenesis of migraine attacks (Arkink et al., 2012;
Charles, 2013; Kato et al., 2010; Kroger and May, 2014; Lipton et al.,
2014; Maniyar et al., 2014; Maniyar et al., 2015; May, 2010, 2013;
Montagna et al., 2010; Morelli et al., 2013; Moulton et al., 2014;
Robert et al., 2013; Sahler, 2013; Schwedt et al., 2015; Seifert et al.,
2012; Zielman et al., 2014). Migraine patients seem to have a normally
regulated ANS when symptom free between attacks. However, during
headache attacks they suffer typically the symptoms of an unbalanced
ANS.
Preliminary studies of patients with chronic inﬂammatory
disorders, such as, granulomatosis with polyangiitis and dialysis
patients with kidney failure (ISRCTN49663124 DOI 10.1186/
ISRCTN49663124) indicate that KOS in the nasal cavity may have
promising anti-inﬂammatory efﬁcacy. This suggests that KOS treat-
ment may has similar impact as the electric stimulation of vagus
nerve (Andersson and Tracey, 2012; Bonaz et al., 2013; Huston,
2012) and might also involve the activation of the cholinergic anti-
inﬂammatory pathway (Tracey, 2002, 2009) through the inter-
connections between cranial nerves in the nasal cavity. We will
investigate this aspect further in the near future.4.3. The main strength and weakness of the study
The strengths of this study include the following: 1) KOS treatment
of on-going acutemigrainewas investigated insideMRI scannerwith si-
multaneous BOLD fMRI recordings; 2) non-invasive KOS treatment was
also conducted in normal volunteers with the identical procedure and
direct comparison between migraine patients and normal controls can
be performed; 3) voxel-wise data-driven analysis based on 3-way
ANOVA modeling of the ICA results was conducted systematically for a
wide range of NIC = 2–19.
The main weaknesses of the study are the following: 1) The
data analysis based on ICA does not provide quantitative metrics
for neurophysiology activity, which renders the results difﬁcult to
interpret and dependent on the input value for NIC. Therefore, it is
necessary to provide complementary results based on ROI analysis of
functional connectivity metrics. 2) There was no data available for mi-
graine patients under migraine-free period. A crossover study design
with the patients as their own controls has deﬁnitely its advantage for
identifying possible prophylactic effect of KOS treatment. 3) Simulta-
neous monitoring of HRV during fMRI measurements would be very
useful for more detailed interpretation of the neurophysiological mech-
anisms underlying KOS treatment of acute migraine. However, the
interfering artifacts caused by the pulsing magnetic ﬁeld gradients
currently limit simultaneous electrocardiography recording during
fMRI.5. Conclusion
The result of this study conﬁrms that KOS treatment is effective both
in relieving acute migraine headache and reducing attack frequency.
Migraine is associated with aberrant intrinsic functional activity in the
limbic and primary sensory systems. KOS in the nasal cavity can regu-
late the intrinsic functional connectivity in the limbic system and re-
store favorably the neurophysiological homeostasis in the ANS. The
preliminary ﬁndings from this pilot study with limited number of par-
ticipants should be further veriﬁed with larger studies in the future.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2016.08.014.
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